These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8097834)

  • 1. Rifampicin-resistant meningococci causing invasive disease and failure of chemoprophylaxis.
    Yagupsky P; Ashkenazi S; Block C
    Lancet; 1993 May; 341(8853):1152-3. PubMed ID: 8097834
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of a rifampicin-resistant meningococcal infection in a teenager.
    Delaune D; Andriamanantena D; Mérens A; Viant E; Aoun O; Ceppa F; Taha MK; Rapp C
    Infection; 2013 Jun; 41(3):705-8. PubMed ID: 23408002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Failure of chemoprophylaxis due to resistance of Neisseria meningitidis to rifampicin].
    Bordessoule A; Hoppé A; Ringuier B; Giniès JL
    Arch Pediatr; 2007 Jan; 14(1):99-100. PubMed ID: 17145173
    [No Abstract]   [Full Text] [Related]  

  • 4. [Chemoprevention in meningococcal meningitis. A health problem or a social response?].
    Garrido Morales P; Domínguez García A; Pumarola Busquets F
    Med Clin (Barc); 1985 Oct; 85(10):418-22. PubMed ID: 3935888
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibiotic resistance among invasive Neisseria meningitidis isolates in England, Wales and Northern Ireland (2010/11 to 2018/19).
    Willerton L; Lucidarme J; Walker A; Lekshmi A; Clark SA; Walsh L; Bai X; Lee-Jones L; Borrow R
    PLoS One; 2021; 16(11):e0260677. PubMed ID: 34843604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rifampin-resistant Neisseria meningitidis.
    Taha MK; Zarantonelli ML; Ruckly C; Giorgini D; Alonso JM
    Emerg Infect Dis; 2006 May; 12(5):859-60. PubMed ID: 16710955
    [No Abstract]   [Full Text] [Related]  

  • 7. First recorded outbreaks of meningococcal disease in the Israel Defence Force: three clusters due to serogroup C and the emergence of resistance to rifampicin.
    Almog R; Block C; Gdalevich M; Lev B; Wiener M; Ashkenazi S
    Infection; 1994; 22(2):69-71. PubMed ID: 8070932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Meningococcal meningitis in Spain (1978-1981). III. Susceptibility of the meningococcal strains isolated from patients and carriers to the main agents used in the treatment and chemoprophylaxis of meningococcal infections].
    Sáez Nieto JA; Vázquez J; Casal J
    Rev Sanid Hig Publica (Madr); 1983; 57(5-6):587-602. PubMed ID: 6422536
    [No Abstract]   [Full Text] [Related]  

  • 9. Rifampin-resistant meningococcal disease in a contact patient given prophylactic rifampin.
    Cooper ER; Ellison RT; Smith GS; Blaser MJ; Reller LB; Paisley JW
    J Pediatr; 1986 Jan; 108(1):93-6. PubMed ID: 3080574
    [No Abstract]   [Full Text] [Related]  

  • 10. [Chemotherapeutics sensitivity of meningococci: therapeutic and prophylactic aspects].
    Berger U
    Dtsch Med Wochenschr; 1973 Jan; 98(3):86-92. PubMed ID: 4630688
    [No Abstract]   [Full Text] [Related]  

  • 11. [Meningococcus profilaxis (author's transl)].
    Pérez Trallero E; Pérez-Yarza E; Ruíz Benito C; Muñóz Baroja I
    Med Clin (Barc); 1979 Nov; 73(9):367-70. PubMed ID: 119117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The chemoprophylaxis of cerebrospinal meningitis using rifampin in a military population.
    Chapalain JC; Guibourdenche M; Perrier-Gros-Claude JD; Bartoli M; Riou JY
    Pathol Biol (Paris); 1992 Mar; 40(3):230-3. PubMed ID: 1608666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Meningococcal epidemic in a boarding school: a rifampicin-resistant secondary case while under chemoprophylaxis].
    Schubiger G; Munzinger J; Dudli C; Wipfli U
    Schweiz Med Wochenschr; 1986 Aug; 116(35):1172-5. PubMed ID: 3094142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meningococcal meningitis.
    Sohal AS; Rao VR
    Br Med J (Clin Res Ed); 1988 May; 296(6634):1471-2. PubMed ID: 3132305
    [No Abstract]   [Full Text] [Related]  

  • 15. Antimicrobial susceptibility of Neisseria meningitidis strains isolated from meningitis cases in Brazil from 2006 to 2008.
    Gorla MC; de Paiva MV; Salgueiro VC; Lemos AP; Brandão AP; Vázquez JA; Brandileone MC
    Enferm Infecc Microbiol Clin; 2011 Feb; 29(2):85-9. PubMed ID: 21345528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The carrier state: Neisseria meningitidis.
    Broome CV
    J Antimicrob Chemother; 1986 Jul; 18 Suppl A():25-34. PubMed ID: 3091563
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of rifampicin on meningococcal carriage in family contacts in northern Nigeria.
    Blakebrough IS; Gilles HM
    J Infect; 1980 Jun; 2(2):137-43. PubMed ID: 6821084
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative efficacy of ceftriaxone and rifampicin in eradicating pharyngeal carriage of group A Neisseria meningitidis.
    Schwartz B; Al-Tobaiqi A; Al-Ruwais A; Fontaine RE; A'ashi J; Hightower AW; Broome CV; Music SI
    Lancet; 1988 Jun; 1(8597):1239-42. PubMed ID: 2897515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulphadiazine resistant group 'A' meningococci isolated during the meningitis outbreak in Delhi (1985).
    Sarkar R; Sharma S; Natarajan R; Agarwal DS
    Indian J Med Res; 1987 Jun; 85():612-6. PubMed ID: 3119473
    [No Abstract]   [Full Text] [Related]  

  • 20. Effectiveness of rifampin in eradicating the meningococcal carrier state in a relatively closed population: emergence of resistant strains.
    Weidmer CE; Dunkel TB; Pettyjohn FS; Smith CD; Leibovitz A
    J Infect Dis; 1971 Aug; 124(2):172-8. PubMed ID: 5001453
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.